Cargando…

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

Coronaviruses are prone to emergence into new host species most recently evidenced by SARS-CoV-2, the causative agent of the COVID-19 pandemic(1). Small animal models that recapitulate SARS-CoV-2 disease are desperately needed to rapidly evaluate medical countermeasures (MCMs)(2,3). SARS-CoV-2 canno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dinnon, Kenneth H., Leist, Sarah R., Schäfer, Alexandra, Edwards, Caitlin E., Martinez, David R., Montgomery, Stephanie A., West, Ande, Yount, Boyd L., Hou, Yixuan J., Adams, Lily E., Gully, Kendra L., Brown, Ariane J., Huang, Emily, Bryant, Matthew D., Choong, Ingrid C., Glenn, Jeffrey S., Gralinski, Lisa E., Sheahan, Timothy P., Baric, Ralph S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034761/ https://www.ncbi.nlm.nih.gov/pubmed/32854108 http://dx.doi.org/10.1038/s41586-020-2708-8

Ejemplares similares

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
por: Leist, Sarah R., et al.
Publicado: (2020)

Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection
por: Edwards, Caitlin E., et al.
Publicado: (2020)

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
por: Martinez, David R., et al.
Publicado: (2021)

Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication
por: Adams, Lily E., et al.
Publicado: (2021)

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
por: Martinez, David R., et al.
Publicado: (2021)

Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis
por: Menachery, Vineet D., et al.
Publicado: (2017)

Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
por: Adams, Lily E., et al.
Publicado: (2023)

Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801
por: Wahl, Angela, et al.
Publicado: (2020)

SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo
por: Hou, Yixuan J., et al.
Publicado: (2020)

Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry
por: Shang, Jian, et al.
Publicado: (2020)

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
por: Gralinski, Lisa E., et al.
Publicado: (2018)

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
por: Pruijssers, Andrea J., et al.
Publicado: (2020)

Correction: Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
por: Deming, Damon, et al.
Publicado: (2007)

Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
por: Deming, Damon, et al.
Publicado: (2006)

Host range, transmissibility and antigenicity of a pangolin coronavirus
por: Hou, Yixuan J., et al.
Publicado: (2023)

Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection
por: Menachery, Vineet D., et al.
Publicado: (2020)

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
por: Martinez, David R., et al.
Publicado: (2021)

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
por: Martinez, David R., et al.
Publicado: (2021)

Virus–Host Interactions Between Nonsecretors and Human Norovirus
por: Lindesmith, Lisa C., et al.
Publicado: (2020)

Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential
por: Martinez, David R., et al.
Publicado: (2023)

MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis
por: Menachery, Vineet D., et al.
Publicado: (2017)

Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis
por: Leist, Sarah R., et al.
Publicado: (2019)

Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
por: Josset, Laurence, et al.
Publicado: (2013)

Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone
por: Gallichotte, Emily N., et al.
Publicado: (2017)

Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
por: Sims, Amy C., et al.
Publicado: (2021)

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
por: Hou, Yixuan J., et al.
Publicado: (2020)

Molecular pathology of emerging coronavirus infections
por: Gralinski, Lisa E, et al.
Publicado: (2015)

SARS-CoV-2 Infection is Effectively Treated and Prevented by EIDD-2801
por: Wahl, Angela, et al.
Publicado: (2021)

Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses
por: Agnihothram, Sudhakar, et al.
Publicado: (2014)

Sars Coronavirus Vaccine Development
por: Baric, Ralph S., et al.
Publicado: (2006)

Characterization of a Pathogenic Full-Length cDNA Clone and Transmission Model for Porcine Epidemic Diarrhea Virus Strain PC22A
por: Beall, Anne, et al.
Publicado: (2016)

Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
por: Brown, Ariane J., et al.
Publicado: (2019)

Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform
por: Graham, Rachel L., et al.
Publicado: (2018)

Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2
por: Tostanoski, Lisa H., et al.
Publicado: (2021)

Efficient Reverse Genetic Systems for Rapid Genetic Manipulation of Emergent and Preemergent Infectious Coronaviruses
por: Cockrell, Adam S., et al.
Publicado: (2017)

Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2
por: Tostanoski, Lisa H., et al.
Publicado: (2021)

Network radar countermeasure systems: integrating radar and radar countermeasures
por: Jiang, Qiuxi
Publicado: (2016)

Sars Cov Replication and Pathogenesis in Human Airway Airway Epithelial Cultures
por: Sims, Amy C., et al.
Publicado: (2006)

Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice.
por: Schäfer, Alexandra, et al.
Publicado: (2021)

Hemorrhagic Fever Viruses: Pathogenesis and Countermeasures
por: Mire, Chad E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rkur4anhbtoiqojc3pq8h94cmk